P

PainReform Ltd
D

PRFX

1.32000
USD
0.06
(4.76%)
مغلق
حجم التداول
1,761
الربح لكل سهم
-48
العائد الربحي
-
P/E
0
حجم السوق
2,657,346
الأخبار المقالات

العنوان: PainReform Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.